News and events

  • All
  • Events
  • Press releases
  • Publications
All
  • All
  • Events
  • Press releases
  • Publications

ExeVir Bio Announces Exceptional Virus Neutralization Potency of its Variant-proof XVR013m Antibody Against the SARS-CoV-2 Variant JN.1

Photo by Önder Örtel on Unsplash
Read More

Join us at the Asia Dengue Summit 2024!

Connect with Florence Herschke, PhD, our head of preclinical development, and Tessa Van Royen, one of our research scientists, next week at the 7th Asia ...
Read More

Poster ESCMID Global 2024 Conference

Poster presented by CSO Viki Bockstal at ESCMID Global, 27–30 April 2024 in Barcelona, Spain
Read More

Member spotlight: ExeVir uses llama-derived antibodies to protect the vulnerable

MEDVIA article featuring ExeVir - Based on the interview with CSO, Viki Bockstal. By Amy LeBlanc. Images: Winter the llama ©Tim Coppens
Read More

Exevir at ECCMID 2024

Our Chief Scientific Officer Viki Bockstal is presenting a poster at ECSMID Global 2024 (formerly known as ECCMID) from 27-30 April in vibrant Barcelona, the ...
Read More